Enovix (NASDAQ:ENVX – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.14) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.01, FiscalAI reports. Enovix had a negative return on equity of 64.29% and a negative net margin of 492.57%.The company had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.95 million. During the same period in the previous year, the business earned ($0.15) EPS. Enovix’s quarterly revenue was up 49.1% on a year-over-year basis. Enovix updated its Q2 2026 guidance to -0.170–0.130 EPS.
Here are the key takeaways from Enovix’s conference call:
- Enovix said it has begun commercial production of its AI-1 smart eyewear battery, with initial shipments underway and production expected to ramp in the second half of 2026.
- The company reported progress on smartphone qualification, saying it and key OEMs have moved away from the legacy 0.7C test in favor of silicon-anode-specific protocols based on more realistic usage patterns.
- Enovix launched its MX1 drone battery at 360 Wh/kg and said demand from drones, defense, and industrial customers is growing, with a Korea pipeline now exceeding $130 million.
- Manufacturing execution at Fab 2 improved, with yields in most zones nearing or exceeding 90%, while Zone 1 dicing remains a bottleneck that the company plans to address with a hybrid laser/mechanical process.
- Q1 revenue came in at $7.6 million, up 49% year over year and above the top end of guidance, while the company ended the quarter with about $582.7 million in cash and marketable securities.
Enovix Price Performance
Shares of ENVX stock traded up $0.32 during trading hours on Wednesday, reaching $7.29. The company had a trading volume of 12,814,977 shares, compared to its average volume of 5,612,262. The company has a debt-to-equity ratio of 1.90, a quick ratio of 8.13 and a current ratio of 8.34. The stock has a fifty day moving average of $5.78 and a 200-day moving average of $7.15. The company has a market capitalization of $1.59 billion, a price-to-earnings ratio of -9.47 and a beta of 2.24. Enovix has a 12-month low of $4.61 and a 12-month high of $16.49.
Analyst Ratings Changes
Institutional Investors Weigh In On Enovix
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Electron Capital Partners LLC increased its holdings in shares of Enovix by 13.8% in the third quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock valued at $80,143,000 after purchasing an additional 972,103 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Enovix by 6.1% in the fourth quarter. Geode Capital Management LLC now owns 4,413,492 shares of the company’s stock valued at $32,268,000 after purchasing an additional 253,906 shares during the last quarter. State Street Corp increased its holdings in shares of Enovix by 2.0% in the fourth quarter. State Street Corp now owns 3,959,029 shares of the company’s stock valued at $28,941,000 after purchasing an additional 77,079 shares during the last quarter. Royal Bank of Canada increased its holdings in shares of Enovix by 18.0% in the fourth quarter. Royal Bank of Canada now owns 2,525,268 shares of the company’s stock valued at $18,461,000 after purchasing an additional 385,983 shares during the last quarter. Finally, Fred Alger Management LLC increased its holdings in shares of Enovix by 58.9% in the fourth quarter. Fred Alger Management LLC now owns 2,292,315 shares of the company’s stock valued at $16,757,000 after purchasing an additional 849,329 shares during the last quarter. Institutional investors and hedge funds own 50.92% of the company’s stock.
Enovix Company Profile
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Featured Stories
- Five stocks we like better than Enovix
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
